RSS

GNBTQ Generex Biotechnology Corp.

Mod: rjs9787 Asst: docj
Last Post: 10/16/26
Followers: 122
Posts Today: 0
Views Today: 1966

GNBTQ Stock Quote & Tools

$0.0000 ▲ +0.0000 (+0.00%) As of Jan 25, 4:00 PM
Last0.0000
$ Chg0.0000
Open—
High—
Beta0.5408
Year High—
Market Cap—
P/B Ratio-0.54
EPS—
Avg Vol (30d)0
Volume—
% Chg+0.00%
Prev Close0.0000
Low—
VWAP0.00000
Year Low—
Total Shares118.45M
Shares Out118.45M
Float116.37M
Exchange
Healthcare Biotechnology & Life Sciences

GNBTQ Stock Message Board Discussion

  1. Pokey123

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 487

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Niagara Networks Boosts TLS 1.3 Decryption to 90+ Gbps

Updated Category News Views 73

In a digital era where encryption is racing ahead like a runaway train, Niagara Networks has stepped up with some serious muscle enhancements to their ePacketron platform. They're not just playing catch-up with the latest TLS 1.3 decryption capabilities; they're leading the charge with a robust over 90 Gbps performance—no small feat in today's encrypted traffic...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 201

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 99

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 247

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 370

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 490

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 474

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 189

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
AI Shopping Surge: WeFetch.ai's Bold Rebrand Move

Updated Category News Views 134

Shifting Gears: GreenCore Solutions Becomes WeFetch.ai Here's a shift you don't see every day. GreenCore Solutions has morphed into WeFetch.ai, aiming to sail the ever-growing AI shopping seas. This isn't just a new nameplate; it's a declaration of intent to dive headfirst into the market dynamics driven by artificial intelligence. It's bold and, frankly, pretty timely....

Continue Reading

Top 5 Most Recently Viewed Articles

E-Bike Motor Market Growth Forecasted to US$150 Billion by 2034

Updated Category News Views 169

Overview of the E-Bike Motor Market The E-Bike Motor market is experiencing significant growth, with projections estimating a valuation of approximately US$ 28.4 billion in 2024. This segment is anticipated to grow at a compound annual growth rate (CAGR) of 16.5% from 2024 to 2034, indicating a robust future filled with potential and opportunity. Current Trends and Market...

Continue Reading
Gilmore Bell Welcomes Nick Weaver as New Associate Attorney

Updated Category News Views 226

Gilmore Bell Welcomes New Associate Attorney Gilmore & Bell, P.C., a prominent public finance law firm, is excited to announce the addition of Nick Weaver to their team in the St. Louis office. With an outstanding educational background and a dedication to public service, Mr. Weaver brings valuable experience and knowledge to the firm. Educational Background of Nick...

Continue Reading
Celebrating Excellence: 2025 CFDA Fashion Awards Highlights

Updated Category News Views 445

2025 CFDA Fashion Awards: A Night of Fashion Recognition The fashion industry gathered to celebrate the outstanding talents at the 2025 CFDA Fashion Awards, marking a significant event in the world of style and creativity. This prestigious ceremony showcased not only established designers but also the emerging talents making their mark in the industry. Highlights of the...

Continue Reading
Deutsche Bank Initiates Stabilization for Grenke's New Bonds

Updated Category News Views 274

Deutsche Bank's Role in Grenke's Latest Bond Issue In a significant move to bolster market confidence, Deutsche Bank AG (NYSE: DB) has announced the initiation of pre-stabilization activities linked to Grenke AG's new bond issuance. This announcement underscores Deutsche Bank's role as the Stabilisation Coordinator, a critical position during financial offerings. The...

Continue Reading
CompTIA Analyzes Employment Trends in Tech Sector

Updated Category News Views 231

Current Trends in the Tech Job Market In recent analyses of the technology job market, signs indicate a slight alteration in employment dynamics. According to the Computing Technology Industry Association (CompTIA), a critical analysis of the recent job figures shows that the unemployment rate in tech occupations has ticked down to 2.5%. This decline is a small relief...

Continue Reading